BiOptix Diagnostics Secures $1,000,000 New Financing Round

  • Feed Type
  • Date
    11/24/2015
  • Company Name
    BiOptix Diagnostics
  • Mailing Address
    1775 38th St. Boulder, CO 80301 USA
  • Company Description
    The company’s mission is to develop its proprietary E-SPR (Enhanced Surface Plasmon Resonance) technology platform for the detection of molecular interactions.
  • Website
    http://www.bioptix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.
  • M&A Terms
  • Venture Investor

Trending on Xconomy